Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human IGF2 Gene Epigenetic and Transcriptional Regulation: At the Core of Developmental Growth and Tumorigenic Behavior. | Biomedicines | 2023 | 37371750 | PubTator, text mining | PubMed |
| Exosomal circRNA: emerging insights into cancer progression and clinical application potential. | J Hematol Oncol | 2023 | 37365670 | PubTator, text mining | PubMed |
| Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors. | Cancer Cell Int | 2023 | 37365581 | PubTator, text mining | PubMed |
| m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. | Mol Cancer | 2023 | 37353784 | PubTator, text mining | PubMed |
| Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells. | Cancer Gene Ther | 2023 | 37353558 | PubTator, text mining | PubMed |
| Roles and implications of mRNA N6 -methyladenosine in cancer. | Cancer Commun (Lond) | 2023 | 37350762 | PubTator, text mining | PubMed |
| Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review). | Int J Mol Med | 2023 | 37350412 | PubTator, text mining | PubMed |
| METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. | J Exp Clin Cancer Res | 2023 | 37340443 | PubTator, text mining | PubMed |
| CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. | J Transl Med | 2023 | 37340423 | PubTator, text mining | PubMed |
| Barriers and facilitators to the implementation of an early intervention in psychosis service in three demonstration sites in Ireland. | BMC Health Serv Res | 2023 | 37337176 | PubTator, text mining | PubMed |
| Successful targeting in situ of an oncogenic nuclear antigen by hapten induced tumor associated autoantibodies (iTAA). | Sci Rep | 2023 | 37336938 | PubTator, text mining | PubMed |
| Large-scale map of RNA binding protein interactomes across the mRNA life-cycle. | bioRxiv | 2023 | 37333282 | PubTator, text mining | PubMed |
| Implications of LncRNAs and CircRNAs in psoriasis: a review. | RNA Biol | 2023 | 37310201 | PubTator, text mining | PubMed |
| Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically. | CNS Neurosci Ther | 2023 | 37309294 | PubTator, text mining | PubMed |
| Cooperativity boosts affinity and specificity of proteins with multiple RNA-binding domains. | NAR Genom Bioinform | 2023 | 37305168 | PubTator, text mining | PubMed |
| Genome-wide detection of m6A-associated SNPs in atrial fibrillation pathogenesis. | Front Cardiovasc Med | 2023 | 37304952 | PubTator, text mining | PubMed |
| A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. | Transl Cancer Res | 2023 | 37304536 | PubTator, text mining | PubMed |
| The role of LIN28B in tumor progression and metastasis in solid tumor entities. | Oncol Res | 2023 | 37304235 | PubTator, text mining | PubMed |
| A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37301543 | PubTator, text mining | PubMed |
| Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response. | Pharmacol Ther | 2023 | 37301330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=34